BTLS.BR

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Agricultural Inputs

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$5M	+82.7%	$-0.33	$-0.36–$-0.29	—	2
2027	$6M	+25.1%	$-0.27	$-0.30–$-0.25	—	2
2028	$14M	+143.8%	$-0.23	$-0.24–$-0.23	—	2

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

DCF fair valuemodel estimate

Intrinsic value

$0.08

Price

$2.00

Implied downside

-96%

Biotalys N.V.

Biotalys N.V. is an agricultural technology firm dedicated to innovating and creating advanced biological solutions for safeguarding both food and cultivated crops. Its product pipeline prominently features biofungicides, bioinsecticides, and biobactericides. Founded in 2013, the company, previously known as Agrosavfe NV, is based in Gent, Belgium.

www.biotalys.com

Employees: 38
IPO / List date: Jul 2, 2021
HQ: BE

Held by traders on TradeandTell

No one on the platform currently holds BTLS.BR.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in BTLS.BR as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded BTLS.BR yet.